rdf:type |
|
lifeskim:mentions |
umls-concept:C0002085,
umls-concept:C0010798,
umls-concept:C0030705,
umls-concept:C0070166,
umls-concept:C0078988,
umls-concept:C0439608,
umls-concept:C0522523,
umls-concept:C0599946,
umls-concept:C0871261,
umls-concept:C1522318,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1707877,
umls-concept:C1948041,
umls-concept:C2911692
|
pubmed:issue |
1
|
pubmed:dateCreated |
2010-12-24
|
pubmed:abstractText |
Carriage of CYP2C19*2 allele is associated with diminished platelet response to clopidogrel. However, the loss-of-function impact of CYP2C19*3 allele on antiplatelet effect of clopidogrel has not been definitely verified. We conducted this study to compare decreased response to clopidogrel according to carriage of CYP2C19*2 vs. *3 allele.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1879-2472
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
127
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
23-8
|
pubmed:meshHeading |
pubmed-meshheading:21075428-Adenosine Diphosphate,
pubmed-meshheading:21075428-Aged,
pubmed-meshheading:21075428-Analysis of Variance,
pubmed-meshheading:21075428-Angioplasty, Balloon, Coronary,
pubmed-meshheading:21075428-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:21075428-Asian Continental Ancestry Group,
pubmed-meshheading:21075428-Chi-Square Distribution,
pubmed-meshheading:21075428-Coronary Artery Disease,
pubmed-meshheading:21075428-Female,
pubmed-meshheading:21075428-Gene Frequency,
pubmed-meshheading:21075428-Genotype,
pubmed-meshheading:21075428-Humans,
pubmed-meshheading:21075428-Male,
pubmed-meshheading:21075428-Middle Aged,
pubmed-meshheading:21075428-Phenotype,
pubmed-meshheading:21075428-Platelet Aggregation,
pubmed-meshheading:21075428-Platelet Aggregation Inhibitors,
pubmed-meshheading:21075428-Platelet Function Tests,
pubmed-meshheading:21075428-Republic of Korea,
pubmed-meshheading:21075428-Risk Assessment,
pubmed-meshheading:21075428-Risk Factors,
pubmed-meshheading:21075428-Ticlopidine,
pubmed-meshheading:21075428-Time Factors,
pubmed-meshheading:21075428-Treatment Outcome
|
pubmed:year |
2011
|
pubmed:articleTitle |
The cytochrome 2C19*2 and *3 alleles attenuate response to clopidogrel similarly in East Asian patients undergoing elective percutaneous coronary intervention.
|
pubmed:affiliation |
Division of Cardiology, Department of Internal Medicine, Gyeongsang National University Hospital, Jinju, South Korea.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|